Long QT Syndrome and Torsades de pointes Ventricular Tachycardia

Social phobia social anxiety disorder

Social anxiety is the third largest psychological problem in the United States today, affecting 15 million Americans a year. It is far from well understood by the medical community.  Examples...

Bone morphogenetic protein rhBMP

Bone morphogenetic protein 2 (rhBMP-2) is approved by the Food and Drug Administration for anterior lumbar interbody fusion and for acute open tibial fractures; rhBMP-7, on the other hand, is approved...

Pubic lice

Pubic lice are small, six-legged creatures that infect the pubic hair area and lay eggs. These lice can also be found in armpit hair and eyebrows. Causes, incidence, and risk factors Pubic lice...

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Prolia®

Class: Supportive Care Generic Name: Denosumab Trade Name: Prolia® How is this drug used? Prolia is used to treat men or postmenopausal women with osteoporosis and a high risk of fracture. Prolia is...

Denosumab (Prolia)

Class: Supportive Care Generic Name: Denosumab Trade Name: Prolia® How is this drug used? Prolia is used to treat men or postmenopausal women with osteoporosis and a high risk of fracture. Prolia is...

Prolia (Denosumab) Approved For Male Osteoporosis

Amgen's Prolia (Denosumab) has been approved for the treatment of osteoporosis in males at high risk of fracture by the Food and Drug Administration (FDA), USA. Denosumab reduced tumor-cell numbers in...

FDA approves Amgen's Prolia for new use

(Reuters) - Amgen Inc, the world's largest biotechnology company, said U.S. health regulators approved its Prolia injection for a new use as a treatment to increase bone mass in men with osteoporosis...

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fractu...

Amgen's Prolia gets FDA nod for men with osteoporosis

The US Food and Drug Administration last week approved a new indication for world biotech leader Amgen's (Nasdaq: AMGN) Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis...

Amgen bone drug Prolia's approval is expanded to include men

The FDA approved Amgen's Prolia injection for use in increasing bone mass in male osteoporosis patients with high fracture ri -More- 

Forteo Plus Prolia Builds Bone (CME/CE)

(MedPage Today) -- Treatment with a combination of teriparatide (Forteo) plus denosumab (Prolia) led to greater increases in bone mineral density in postmenopausal women with osteoporosis than either...

The Physiological Function of Store-operated Calcium Entry.

Store-operated Ca(2+) entry is a process whereby the depletion of intracellular Ca(2+) stores signals the opening of plasma membrane Ca(2+) channels. It has long been thought that the main function of...

System consolidation of memory during sleep.

Over the past two decades, research has accumulated compelling evidence that sleep supports the formation of long-term memory. The standard two-stage memory model that has been originally elaborated f...

Improving Service Accessibility in Service-Oriented HIS.

Nowadays, new trend in design and implementation of Hospital Information System (HIS) is towards using Web-based Service-Oriented Architecture (SOA). However, the standard SOA includes an insensitive...

In pursuit of Irving and Scholander: a review of oxygen store management in seals and penguins.

Since the introduction of the aerobic dive limit (ADL) 30 years ago, the concept that most dives of marine mammals and sea birds are aerobic in nature has dominated the interpretation of their diving...

Calcium-activated K(+) channel (K(Ca)3.1) activity during Ca(2+) store depletion and store-operated Ca(2+) entry in human macrophages.

STIM1 'senses' decreases in endoplasmic reticular (ER) luminal Ca(2+) and induces store-operated Ca(2+) (SOC) entry through plasma membrane Orai channels. The Ca(2+)/calmodulin-activated K(+) channel...